These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35998877)

  • 1. The Asthma Impairment and Risk Questionnaire (AIRQ) Control Level Predicts Future Risk of Asthma Exacerbations.
    Beuther DA; Murphy KR; Zeiger RS; Wise RA; McCann W; Reibman J; George M; Gilbert I; Eudicone JM; Gandhi HN; Ross M; Coyne KS; Chipps B
    J Allergy Clin Immunol Pract; 2022 Dec; 10(12):3204-3212.e2. PubMed ID: 35998877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Clinical Characteristics and Biomarkers on Asthma Impairment and Risk Questionnaire Exacerbation Prediction Ability.
    Murphy KR; Beuther DA; Chipps BE; Wise RA; McCann WA; Reibman J; George M; Gilbert I; Eudicone JM; Gandhi HN; Ross M; Coyne KS; Zeiger RS
    J Allergy Clin Immunol Pract; 2024 Aug; 12(8):2092-2101.e4. PubMed ID: 38705273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study.
    Haselkorn T; Fish JE; Zeiger RS; Szefler SJ; Miller DP; Chipps BE; Simons FE; Weiss ST; Wenzel SE; Borish L; Bleecker ER;
    J Allergy Clin Immunol; 2009 Nov; 124(5):895-902.e1-4. PubMed ID: 19811812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating construct validity of the Asthma Impairment and Risk Questionnaire using a 3-month exacerbation recall.
    Chipps BE; Murphy KR; Wise RA; McCann WA; Beuther DA; Reibman J; George M; Gilbert I; Eudicone JM; Gandhi HN; Harding G; Ross M; Zeiger RS
    Ann Allergy Asthma Immunol; 2022 May; 128(5):544-552.e3. PubMed ID: 35123077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure.
    Murphy KR; Chipps B; Beuther DA; Wise RA; McCann W; Gilbert I; Eudicone JM; Gandhi HN; Harding G; Coyne KS; Zeiger RS;
    J Allergy Clin Immunol Pract; 2020; 8(7):2263-2274.e5. PubMed ID: 32387166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing assessment of asthma control with a composite tool: The Asthma Impairment and Risk Questionnaire.
    Chipps BE; Zeiger RS; Beuther DA; Wise RA; McCann W; Reibman J; George M; Gilbert I; Eudicone JM; Coyne KS; Harding G; Murphy KR
    Ann Allergy Asthma Immunol; 2024 Jul; 133(1):49-56. PubMed ID: 38494113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very Poorly Controlled Asthma in Urban Minority Children: Lessons Learned.
    Butz AM; Bellin M; Tsoukleris M; Mudd SS; Kub J; Ogborn J; Morphew T; Lewis-Land C; Bollinger ME
    J Allergy Clin Immunol Pract; 2018; 6(3):844-852. PubMed ID: 28958744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the German version of the Asthma Impairment and Risk Questionnaire (AIRQ).
    Kanniess F; Defosse K; Lommatzsch M; Schultz T; Timmermann H; Schmidt O; Heindl S; Baumann HJ; Buhl R; Taube C; Höing F; Korn S
    Pneumologie; 2024 Nov; 78(11):912-921. PubMed ID: 38991526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing meaningful change in the Asthma Impairment and Risk Questionnaire.
    McCann W; Murphy KR; Zeiger RS; Beuther DA; Wise RA; Reibman J; George M; Gilbert I; Eudicone JM; Gandhi HN; Cutts K; Coyne KS; Chipps B
    Ann Allergy Asthma Immunol; 2024 Aug; 133(2):152-158. PubMed ID: 38369256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship Between Asthma Control as Measured by the Asthma Impairment and Risk Questionnaire (AIRQ) and Patient Perception of Disease Status, Health-Related Quality of Life, and Treatment Adherence.
    Reibman J; Chipps BE; Zeiger RS; Beuther DA; Wise RA; McCann W; Gilbert I; Eudicone JM; Gandhi HN; Harding G; Cutts K; Coyne KS; Murphy KR; George M
    J Asthma Allergy; 2023; 16():59-72. PubMed ID: 36636702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe asthma exacerbations in the United States:: Incidence, characteristics, predictors, and effects of biologic treatments.
    Trevor J; Lugogo N; Carr W; Moore WC; Soong W; Panettieri RA; Desai P; Trudo F; Ambrose CS
    Ann Allergy Asthma Immunol; 2021 Nov; 127(5):579-587.e1. PubMed ID: 34273485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Asthma Impairment and Risk Questionnaire enhances the assessment of asthma control.
    Chipps B; Zeiger RS; Beuther DA; Reibman J; Wise RA; McCann W; Gilbert I; Eudicone JM; Gandhi HN; Harding G; Cutts K; George M; Murphy KR
    Ann Allergy Asthma Immunol; 2023 Oct; 131(4):436-443.e1. PubMed ID: 37105501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of exacerbations on lung function, resource utilization, and productivity: results from an observational, prospective study in adults with uncontrolled asthma.
    Wisnivesky J; Federmann E; Eckert L; West E; Amand C; Kamar D; Teper A; Khan AH
    J Asthma; 2023 Jun; 60(6):1072-1079. PubMed ID: 36218309
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictors of asthma exacerbation among patients with poorly controlled asthma despite inhaled corticosteroid treatment.
    Quezada W; Kwak ES; Reibman J; Rogers L; Mastronarde J; Teague WG; Wei C; Holbrook JT; DiMango E
    Ann Allergy Asthma Immunol; 2016 Feb; 116(2):112-7. PubMed ID: 26712474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated with Asthma Exacerbations During Pregnancy.
    Bokern MP; Robijn AL; Jensen ME; Barker D; Callaway L; Clifton V; Wark P; Giles W; Mattes J; Peek M; Attia J; Seeho S; Abbott A; Gibson PG; Murphy VE
    J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4343-4352.e4. PubMed ID: 34403838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA.
    Suruki RY; Daugherty JB; Boudiaf N; Albers FC
    BMC Pulm Med; 2017 Apr; 17(1):74. PubMed ID: 28449686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between episodes of upper respiratory infection and exacerbations in adult patients with asthma.
    Tomita K; Sano H; Iwanaga T; Ishihara K; Ichinose M; Kawase I; Kimura H; Hirata K; Fujimura M; Mishima M; Tohda Y
    J Asthma; 2012 Apr; 49(3):253-9. PubMed ID: 22376075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthma exacerbation rates in adults are unchanged over a 5-year period despite high-intensity therapy.
    Schatz M; Meckley LM; Kim M; Stockwell BT; Castro M
    J Allergy Clin Immunol Pract; 2014; 2(5):570-4.e1. PubMed ID: 25213050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
    Petsky HL; Li A; Chang AB
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD005603. PubMed ID: 28837221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Asthma Exacerbation and Treatment Failure in Adults and Adolescents with Well-controlled Asthma during Continuation and Step-Down Therapy.
    DiMango E; Rogers L; Reibman J; Gerald LB; Brown M; Sugar EA; Henderson R; Holbrook JT
    Ann Am Thorac Soc; 2018 Aug; 15(8):955-961. PubMed ID: 29863899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.